ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Arbidol Tablets (COVID-19) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35G7975
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Arbidol Tablets COVID 19 Market Insights Forecast to 2028
BUY CHAPTERS

Global Arbidol Tablets (COVID-19) Market Research Report 2025

Code: QYRE-Auto-35G7975
Report
July 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical

Arbidol Tablets (COVID-19) Market

The global market for Arbidol Tablets (COVID-19) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Arbidol Tablets (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arbidol Tablets (COVID-19).
The Arbidol Tablets (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Arbidol Tablets (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arbidol Tablets (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Arbidol Tablets (COVID-19) Market Report

Report Metric Details
Report Name Arbidol Tablets (COVID-19) Market
Segment by Type
  • 50mg
  • 100mg
Segment by Application
  • Anti Influenza Virus
  • COVID-19
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical, Simcere Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Arbidol Tablets (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Arbidol Tablets (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Arbidol Tablets (COVID-19) Market report?

Ans: The main players in the Arbidol Tablets (COVID-19) Market are JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical, Simcere Pharmaceutical

What are the Application segmentation covered in the Arbidol Tablets (COVID-19) Market report?

Ans: The Applications covered in the Arbidol Tablets (COVID-19) Market report are Anti Influenza Virus, COVID-19

What are the Type segmentation covered in the Arbidol Tablets (COVID-19) Market report?

Ans: The Types covered in the Arbidol Tablets (COVID-19) Market report are 50mg, 100mg

1 Arbidol Tablets (COVID-19) Market Overview
1.1 Product Definition
1.2 Arbidol Tablets (COVID-19) by Type
1.2.1 Global Arbidol Tablets (COVID-19) Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 100mg
1.3 Arbidol Tablets (COVID-19) by Application
1.3.1 Global Arbidol Tablets (COVID-19) Market Value by Application (2024 VS 2031)
1.3.2 Anti Influenza Virus
1.3.3 COVID-19
1.4 Global Arbidol Tablets (COVID-19) Market Size Estimates and Forecasts
1.4.1 Global Arbidol Tablets (COVID-19) Revenue 2020-2031
1.4.2 Global Arbidol Tablets (COVID-19) Sales 2020-2031
1.4.3 Global Arbidol Tablets (COVID-19) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Arbidol Tablets (COVID-19) Market Competition by Manufacturers
2.1 Global Arbidol Tablets (COVID-19) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Arbidol Tablets (COVID-19) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Arbidol Tablets (COVID-19) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Arbidol Tablets (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Arbidol Tablets (COVID-19), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Arbidol Tablets (COVID-19), Product Type & Application
2.7 Global Key Manufacturers of Arbidol Tablets (COVID-19), Date of Enter into This Industry
2.8 Global Arbidol Tablets (COVID-19) Market Competitive Situation and Trends
2.8.1 Global Arbidol Tablets (COVID-19) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Arbidol Tablets (COVID-19) Players Market Share by Revenue
2.8.3 Global Arbidol Tablets (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Arbidol Tablets (COVID-19) Market Scenario by Region
3.1 Global Arbidol Tablets (COVID-19) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Arbidol Tablets (COVID-19) Sales by Region: 2020-2031
3.2.1 Global Arbidol Tablets (COVID-19) Sales by Region: 2020-2025
3.2.2 Global Arbidol Tablets (COVID-19) Sales by Region: 2026-2031
3.3 Global Arbidol Tablets (COVID-19) Revenue by Region: 2020-2031
3.3.1 Global Arbidol Tablets (COVID-19) Revenue by Region: 2020-2025
3.3.2 Global Arbidol Tablets (COVID-19) Revenue by Region: 2026-2031
3.4 North America Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.4.1 North America Arbidol Tablets (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Arbidol Tablets (COVID-19) Sales by Country (2020-2031)
3.4.3 North America Arbidol Tablets (COVID-19) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.5.1 Europe Arbidol Tablets (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Arbidol Tablets (COVID-19) Sales by Country (2020-2031)
3.5.3 Europe Arbidol Tablets (COVID-19) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Arbidol Tablets (COVID-19) Market Facts & Figures by Region
3.6.1 Asia Pacific Arbidol Tablets (COVID-19) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Arbidol Tablets (COVID-19) Sales by Region (2020-2031)
3.6.3 Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.7.1 Latin America Arbidol Tablets (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Arbidol Tablets (COVID-19) Sales by Country (2020-2031)
3.7.3 Latin America Arbidol Tablets (COVID-19) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Arbidol Tablets (COVID-19) Market Facts & Figures by Country
3.8.1 Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Arbidol Tablets (COVID-19) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Arbidol Tablets (COVID-19) Sales by Type (2020-2031)
4.1.1 Global Arbidol Tablets (COVID-19) Sales by Type (2020-2025)
4.1.2 Global Arbidol Tablets (COVID-19) Sales by Type (2026-2031)
4.1.3 Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2020-2031)
4.2 Global Arbidol Tablets (COVID-19) Revenue by Type (2020-2031)
4.2.1 Global Arbidol Tablets (COVID-19) Revenue by Type (2020-2025)
4.2.2 Global Arbidol Tablets (COVID-19) Revenue by Type (2026-2031)
4.2.3 Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2020-2031)
4.3 Global Arbidol Tablets (COVID-19) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Arbidol Tablets (COVID-19) Sales by Application (2020-2031)
5.1.1 Global Arbidol Tablets (COVID-19) Sales by Application (2020-2025)
5.1.2 Global Arbidol Tablets (COVID-19) Sales by Application (2026-2031)
5.1.3 Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2020-2031)
5.2 Global Arbidol Tablets (COVID-19) Revenue by Application (2020-2031)
5.2.1 Global Arbidol Tablets (COVID-19) Revenue by Application (2020-2025)
5.2.2 Global Arbidol Tablets (COVID-19) Revenue by Application (2026-2031)
5.2.3 Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2020-2031)
5.3 Global Arbidol Tablets (COVID-19) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 JSC Pharmstandard
6.1.1 JSC Pharmstandard Company Information
6.1.2 JSC Pharmstandard Description and Business Overview
6.1.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Product Portfolio
6.1.5 JSC Pharmstandard Recent Developments/Updates
6.2 Jiangsu Wuzhong Pharmaceutical
6.2.1 Jiangsu Wuzhong Pharmaceutical Company Information
6.2.2 Jiangsu Wuzhong Pharmaceutical Description and Business Overview
6.2.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
6.2.5 Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
6.3 CSPC Ouyi Pharmaceutical
6.3.1 CSPC Ouyi Pharmaceutical Company Information
6.3.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.3.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
6.3.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.4 Simcere Pharmaceutical
6.4.1 Simcere Pharmaceutical Company Information
6.4.2 Simcere Pharmaceutical Description and Business Overview
6.4.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
6.4.5 Simcere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Arbidol Tablets (COVID-19) Industry Chain Analysis
7.2 Arbidol Tablets (COVID-19) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Arbidol Tablets (COVID-19) Production Mode & Process Analysis
7.4 Arbidol Tablets (COVID-19) Sales and Marketing
7.4.1 Arbidol Tablets (COVID-19) Sales Channels
7.4.2 Arbidol Tablets (COVID-19) Distributors
7.5 Arbidol Tablets (COVID-19) Customer Analysis
8 Arbidol Tablets (COVID-19) Market Dynamics
8.1 Arbidol Tablets (COVID-19) Industry Trends
8.2 Arbidol Tablets (COVID-19) Market Drivers
8.3 Arbidol Tablets (COVID-19) Market Challenges
8.4 Arbidol Tablets (COVID-19) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
List of Tables
 Table 1. Global Arbidol Tablets (COVID-19) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Arbidol Tablets (COVID-19) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Arbidol Tablets (COVID-19) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Arbidol Tablets (COVID-19) Sales (M Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Arbidol Tablets (COVID-19) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Arbidol Tablets (COVID-19) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Arbidol Tablets (COVID-19) Average Price (US$/K Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Arbidol Tablets (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Arbidol Tablets (COVID-19), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Arbidol Tablets (COVID-19), Product Type & Application
 Table 12. Global Key Manufacturers of Arbidol Tablets (COVID-19), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Arbidol Tablets (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arbidol Tablets (COVID-19) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Arbidol Tablets (COVID-19) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Arbidol Tablets (COVID-19) Sales by Region (2020-2025) & (M Pcs)
 Table 18. Global Arbidol Tablets (COVID-19) Sales Market Share by Region (2020-2025)
 Table 19. Global Arbidol Tablets (COVID-19) Sales by Region (2026-2031) & (M Pcs)
 Table 20. Global Arbidol Tablets (COVID-19) Sales Market Share by Region (2026-2031)
 Table 21. Global Arbidol Tablets (COVID-19) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Arbidol Tablets (COVID-19) Revenue Market Share by Region (2020-2025)
 Table 23. Global Arbidol Tablets (COVID-19) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Arbidol Tablets (COVID-19) Revenue Market Share by Region (2026-2031)
 Table 25. North America Arbidol Tablets (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Arbidol Tablets (COVID-19) Sales by Country (2020-2025) & (M Pcs)
 Table 27. North America Arbidol Tablets (COVID-19) Sales by Country (2026-2031) & (M Pcs)
 Table 28. North America Arbidol Tablets (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Arbidol Tablets (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Arbidol Tablets (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Arbidol Tablets (COVID-19) Sales by Country (2020-2025) & (M Pcs)
 Table 32. Europe Arbidol Tablets (COVID-19) Sales by Country (2026-2031) & (M Pcs)
 Table 33. Europe Arbidol Tablets (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Arbidol Tablets (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Arbidol Tablets (COVID-19) Sales by Region (2020-2025) & (M Pcs)
 Table 37. Asia Pacific Arbidol Tablets (COVID-19) Sales by Region (2026-2031) & (M Pcs)
 Table 38. Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Arbidol Tablets (COVID-19) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Arbidol Tablets (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Arbidol Tablets (COVID-19) Sales by Country (2020-2025) & (M Pcs)
 Table 42. Latin America Arbidol Tablets (COVID-19) Sales by Country (2026-2031) & (M Pcs)
 Table 43. Latin America Arbidol Tablets (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Arbidol Tablets (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Arbidol Tablets (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2020-2025) & (M Pcs)
 Table 47. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2026-2031) & (M Pcs)
 Table 48. Middle East and Africa Arbidol Tablets (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Arbidol Tablets (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Type (2020-2025)
 Table 51. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Type (2026-2031)
 Table 52. Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2020-2025)
 Table 53. Global Arbidol Tablets (COVID-19) Sales Market Share by Type (2026-2031)
 Table 54. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2020-2025)
 Table 57. Global Arbidol Tablets (COVID-19) Revenue Market Share by Type (2026-2031)
 Table 58. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Type (2020-2025)
 Table 59. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Type (2026-2031)
 Table 60. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Application (2020-2025)
 Table 61. Global Arbidol Tablets (COVID-19) Sales (M Pcs) by Application (2026-2031)
 Table 62. Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2020-2025)
 Table 63. Global Arbidol Tablets (COVID-19) Sales Market Share by Application (2026-2031)
 Table 64. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Arbidol Tablets (COVID-19) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2020-2025)
 Table 67. Global Arbidol Tablets (COVID-19) Revenue Market Share by Application (2026-2031)
 Table 68. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Application (2020-2025)
 Table 69. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Application (2026-2031)
 Table 70. JSC Pharmstandard Company Information
 Table 71. JSC Pharmstandard Description and Business Overview
 Table 72. JSC Pharmstandard Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2020-2025)
 Table 73. JSC Pharmstandard Arbidol Tablets (COVID-19) Product
 Table 74. JSC Pharmstandard Recent Developments/Updates
 Table 75. Jiangsu Wuzhong Pharmaceutical Company Information
 Table 76. Jiangsu Wuzhong Pharmaceutical Description and Business Overview
 Table 77. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2020-2025)
 Table 78. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product
 Table 79. Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
 Table 80. CSPC Ouyi Pharmaceutical Company Information
 Table 81. CSPC Ouyi Pharmaceutical Description and Business Overview
 Table 82. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2020-2025)
 Table 83. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product
 Table 84. CSPC Ouyi Pharmaceutical Recent Developments/Updates
 Table 85. Simcere Pharmaceutical Company Information
 Table 86. Simcere Pharmaceutical Description and Business Overview
 Table 87. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/K Pcs) and Gross Margin (2020-2025)
 Table 88. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product
 Table 89. Simcere Pharmaceutical Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Arbidol Tablets (COVID-19) Distributors List
 Table 93. Arbidol Tablets (COVID-19) Customers List
 Table 94. Arbidol Tablets (COVID-19) Market Trends
 Table 95. Arbidol Tablets (COVID-19) Market Drivers
 Table 96. Arbidol Tablets (COVID-19) Market Challenges
 Table 97. Arbidol Tablets (COVID-19) Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Arbidol Tablets (COVID-19)
 Figure 2. Global Arbidol Tablets (COVID-19) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Arbidol Tablets (COVID-19) Market Share by Type: 2024 & 2031
 Figure 4. 50mg Product Picture
 Figure 5. 100mg Product Picture
 Figure 6. Global Arbidol Tablets (COVID-19) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Arbidol Tablets (COVID-19) Market Share by Application: 2024 & 2031
 Figure 8. Anti Influenza Virus
 Figure 9. COVID-19
 Figure 10. Global Arbidol Tablets (COVID-19) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Arbidol Tablets (COVID-19) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Arbidol Tablets (COVID-19) Sales (2020-2031) & (M Pcs)
 Figure 13. Global Arbidol Tablets (COVID-19) Average Price (US$/K Pcs) & (2020-2031)
 Figure 14. Arbidol Tablets (COVID-19) Report Years Considered
 Figure 15. Arbidol Tablets (COVID-19) Sales Share by Manufacturers in 2024
 Figure 16. Global Arbidol Tablets (COVID-19) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Arbidol Tablets (COVID-19) Players: Market Share by Revenue in Arbidol Tablets (COVID-19) in 2024
 Figure 18. Arbidol Tablets (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Arbidol Tablets (COVID-19) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Arbidol Tablets (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 21. North America Arbidol Tablets (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Arbidol Tablets (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Arbidol Tablets (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Arbidol Tablets (COVID-19) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Arbidol Tablets (COVID-19) Revenue Market Share by Region (2020-2031)
 Figure 33. China Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Arbidol Tablets (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Arbidol Tablets (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Arbidol Tablets (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Arbidol Tablets (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Arbidol Tablets (COVID-19) by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Arbidol Tablets (COVID-19) by Type (2020-2031)
 Figure 54. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Arbidol Tablets (COVID-19) by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Arbidol Tablets (COVID-19) by Application (2020-2031)
 Figure 57. Global Arbidol Tablets (COVID-19) Price (US$/K Pcs) by Application (2020-2031)
 Figure 58. Arbidol Tablets (COVID-19) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Arbidol Hydrochloride COVID 19 Market Research Report 2024
Global Arotinolol Hydrochloride API Market Research Report 2024
Global Arbidol Hcl Market Research Report 2024
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
Influenza Antiviral Drugs Market
Specific Antiviral Drugs for COVID 19 Market
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030
Global Traditional Chinese Medicine for COVID 19 Market Research Report 2024
Global COVID 19 Medicine Market Research Report 2024
Arbidol API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Favipiravir Tablets Market Research Report 2025
Global COVID 19 Liquid Mask Market Research Report 2024
Rimantadine Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Antiviral Treatment Market Research Report 2024
Chemical Medication in COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Influenza Virus Chinese Medicine Market Research Report 2024
Global Anti HBV Drugs Market Research Report 2025
Nebivolol Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions